1. Home
  2. BOLD vs UONEK Comparison

BOLD vs UONEK Comparison

Compare BOLD & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • UONEK
  • Stock Information
  • Founded
  • BOLD 2018
  • UONEK 1980
  • Country
  • BOLD United States
  • UONEK United States
  • Employees
  • BOLD N/A
  • UONEK N/A
  • Industry
  • BOLD
  • UONEK Broadcasting
  • Sector
  • BOLD
  • UONEK Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • UONEK Nasdaq
  • Market Cap
  • BOLD 24.4M
  • UONEK 28.1M
  • IPO Year
  • BOLD 2024
  • UONEK N/A
  • Fundamental
  • Price
  • BOLD $1.19
  • UONEK $0.63
  • Analyst Decision
  • BOLD Buy
  • UONEK
  • Analyst Count
  • BOLD 3
  • UONEK 0
  • Target Price
  • BOLD $4.00
  • UONEK N/A
  • AVG Volume (30 Days)
  • BOLD 105.1K
  • UONEK 297.2K
  • Earning Date
  • BOLD 08-11-2025
  • UONEK 08-19-2025
  • Dividend Yield
  • BOLD N/A
  • UONEK N/A
  • EPS Growth
  • BOLD N/A
  • UONEK N/A
  • EPS
  • BOLD N/A
  • UONEK N/A
  • Revenue
  • BOLD N/A
  • UONEK $437,499,000.00
  • Revenue This Year
  • BOLD N/A
  • UONEK N/A
  • Revenue Next Year
  • BOLD N/A
  • UONEK N/A
  • P/E Ratio
  • BOLD N/A
  • UONEK N/A
  • Revenue Growth
  • BOLD N/A
  • UONEK N/A
  • 52 Week Low
  • BOLD $1.00
  • UONEK $0.44
  • 52 Week High
  • BOLD $4.72
  • UONEK $1.51
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • UONEK 47.72
  • Support Level
  • BOLD N/A
  • UONEK $0.57
  • Resistance Level
  • BOLD N/A
  • UONEK $0.70
  • Average True Range (ATR)
  • BOLD 0.00
  • UONEK 0.10
  • MACD
  • BOLD 0.00
  • UONEK -0.00
  • Stochastic Oscillator
  • BOLD 0.00
  • UONEK 20.70

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: